EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Juvenile Spondyloarthropathies: Diagnostic and Therapeutic Advances—A Narrative Review

Călin Lazăr, Mirela Crișan, Oana-Iulia Man iD, Lucia Maria Sur iD, Gabriel Samașca iD, Alexandru Cristian Bolunduț iD

Journal of Clinical Medicine · 03.05.2025 · 14 (9) · 3166

DOI: 10.3390/jcm14093166 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.05.2025. Verfasst von Călin Lazăr und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1st Paediatric Clinic, Emergency Clinical Hospital for Children, 400370 Cluj-Napoca, Romania. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spondyloarthropathies (SpAs) represent a diverse group of seronegative immune-mediated inflammatory diseases characterized by a genetic predisposition and an association with human leukocyte antigen-B27. This narrative review aims to explore juvenile spondyloarthropathies (JSpAs), their classification, clinical manifestations, diagnostic challenges, and contemporary treatment strategies. According to the International League of Associations for Rheumatology criteria, JSpAs include several specific forms: enthesitis-related arthritis, psoriatic arthritis, and undifferentiated arthritis. Despite established classifications, the terms and definitions surrounding these conditions can often lead to confusion among healthcare professionals. This ambiguity underscores the need for a standardized approach to nosological classification. The clinical presentation of JSpAs can be multifaceted, encompassing both articular and extra-articular manifestations. Articular symptoms may include enthesitis and varying forms of arthritis, while extra-articular involvement can range from uveitis to gastrointestinal, cardiovascular, pulmonary, neurological, and renal complications. These diverse manifestations highlight the systemic nature of the disease and the importance of a holistic approach to diagnosis and treatment. While laboratory tests for SpAs are often non-specific, imaging modalities such as musculoskeletal ultrasound and magnetic resonance imaging play a crucial role in the early detection of inflammatory lesions. These imaging techniques can provide valuable insights into disease progression and aid in the formulation of appropriate treatment plans. Current treatment guidelines advocate for a “stepwise” approach to therapy, beginning with nonsteroidal anti-inflammatory drugs and progressing to glucocorticoids, disease-modifying antirheumatic drugs, and biological agents, particularly anti-tumor necrosis factor alpha agents. The primary objective of treatment is to achieve clinical remission or, at a minimum, to attain low disease activity. Regular monitoring of disease activity is imperative; however, the lack of validated assessment tools for the pediatric population remains a significant challenge. JSpAs pose unique challenges in terms of diagnosis and management due to their diverse manifestations and the complexities of their classification. Ongoing research and clinical efforts are essential to refine our understanding of these conditions, improve treatment outcomes, and enhance quality of life for affected children and their families. Effective management hinges on early detection, individualized treatment plans, and continuous monitoring, ensuring that patients receive the most appropriate care tailored to their specific needs.

Schlagwörter

Stichwörter der Autor:innen

biological treatmententhesitis-related arthritisjuvenile spondyloarthritis

Autor:innen und Institutionen

  • 1st Paediatric Clinic, Emergency Clinical Hospital for Children, 400370 Cluj-Napoca, Romania.
  • 1st Department of Paediatrics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400370 Cluj-Napoca, Romania.
  • Department of Immunology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400162 Cluj-Napoca, Romania.

ORCID-Profile: Oana-Iulia Man, Lucia Maria Sur, Gabriel Samașca, Alexandru Cristian Bolunduț

Zitieren

APA

Lazăr, C., Crișan, M., Man, O. I., Sur, L. M., Samașca, G., & Bolunduț, A. C. (2025). Juvenile Spondyloarthropathies: Diagnostic and Therapeutic Advances—A Narrative Review. Journal of Clinical Medicine, 14(9), 3166. https://doi.org/10.3390/jcm14093166

Vancouver

Lazăr C, Crișan M, Man OI, Sur LM, Samașca G, Bolunduț AC. Juvenile Spondyloarthropathies: Diagnostic and Therapeutic Advances—A Narrative Review. Journal of Clinical Medicine. 2025;14(9):3166. doi:10.3390/jcm14093166

BibTeX
@article{Lazr2025,
  author = {Lazăr, Călin and Crișan, Mirela and Man, Oana-Iulia and Sur, Lucia Maria and Samașca, Gabriel and Bolunduț, Alexandru Cristian},
  title = {Juvenile Spondyloarthropathies: Diagnostic and Therapeutic Advances—A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {9},
  pages = {3166},
  doi = {10.3390/jcm14093166}
}
Kostenlos starten →